Home/Filings/4/0001209191-19-036287
4//SEC Filing

ANSARI ABID 4

Accession 0001209191-19-036287

CIK 0001357874other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 10:27 AM ET

Size

14.6 KB

Accession

0001209191-19-036287

Insider Transaction Report

Form 4
Period: 2019-06-10
ANSARI ABID
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-06-1096,61843,917 total
    Exercise: $1.20Exp: 2026-08-10Common Stock (96,618 underlying)
  • Exercise/Conversion

    Common Stock

    2019-06-10$1.18/sh+7,027$8,292103,645 total
  • Exercise/Conversion

    Common Stock

    2019-06-10$1.20/sh+96,618$115,94296,618 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-06-107,0277,026 total
    Exercise: $1.18Exp: 2027-03-23Common Stock (7,027 underlying)
Footnotes (2)
  • [F1]The option vests as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the following 36 months.
  • [F2]The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1
  • filerCIK 0001770149

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 10:27 AM ET
Size
14.6 KB